Search results

The history of Swedish day-care is examined in a new study that provides insight into Sweden's day-care system during the early 20th century. Together with Luciana Quaranta, Annika Elwert has looked at which factors influenced enrolment in day-care centres in southern Sweden for children born between 1900 and 1935. The study shows that at the beginning of the 20th century it was unusual for childr

https://www.soc.lu.se/en/article/who-was-swedish-day-care-meant - 2025-10-19

David Wästerfors, Veronika Burcar Alm and Erik Hannerz have published an article in New Media & Society dealing with crime case discussions on the Swedish platform Flashback. The article shows how the interactions form a "bumpy" path as the Flashback-writers together try to achieve knowledge, evidence and authority regarding the various crimes being discussed. Much of today's public discussion on

https://www.soc.lu.se/en/article/sleuthing-online-bumpy-path-net-detective - 2025-10-19

Friday 5 May Elton Chan defended his thesis which explores the production and transformation of public spaces in Hong Kong, a city that is steeped in neoliberal ideals and has seen substantial deterioration in terms of democratic rights and freedoms in recent years. Drawing upon recent protest movements in Hong Kong and the ways in which protesters appropriated and transformed different urban spac

https://www.soc.lu.se/en/article/elton-chan-our-new-doctor-sociology-has-defended-his-thesis-public-space-hong-kong - 2025-10-19

On 11 May, Lars Crusefalk finished his PhD studies with a successful defence of his thesis "Financial journeys: Reasoning about debt and money among young adults in Sweden". He is the 132nd doctoral candidate to complete PhD studies at the Department of Sociology. Swedish households are among the most indebted in the EU. Home loans make up most of the debt, but other credit usage is becoming incre

https://www.soc.lu.se/en/article/lars-crusefalk-ends-phd-student-journey-and-transitions-doctor-sociology - 2025-10-19

The neoliberal agenda dominating the EU for the past 40 years has been a severe challenge for the trade unions, which have lost organisational strength. Even in Sweden, union density has declined, but the country still has the second highest unionisation rate in the world, only surpassed by Iceland. Almost seven out of ten employees in Sweden are union members. In June of this year, the European T

https://www.soc.lu.se/en/article/anders-kjellberg-co-authors-comprehensive-book-trade-unions-eu-countries - 2025-10-19

The proportion of unionised blue-collar and white-collar workers fell in 2022 after an increase in the pandemic years of 2020 and 2021. Despite this, Sweden has the world's second highest level of unionisation. This is shown in the report 'The Swedish model from a Nordic perspective: unionisation and the new basic agreement' by Professor Anders Kjellberg for the think tank Arena Idé. The share of

https://www.soc.lu.se/en/article/sweden-world-leading-union-membership-despite-declining-union-density - 2025-10-19

Don't miss the latest episode of MultiPark's podcast Meet our scientists. MultiPark's newest research group leader, Henrik Ahlenius, shares his expertise about stem cells in aging and neurodegenerative diseases. In this episode, Henrik explains the fascinating interplay between aging, neurodegenerative diseases and stem cells - critical areas of study that Henrik Ahlenius has passionately pursued

https://www.multipark.lu.se/article/meet-our-scientists-podcast-henrik-ahlenius-about-stem-cells-aging-and-neurodegeneration - 2025-10-19

This week marked the kickoff of MultiPark's Advanced Neuroscience Course. In this exclusive program, students from around the world unite to explore neuroscience and the complexities of neurodegenerative diseases. During the Advanced Neuroscience Course, students gain insights from leading researchers and get hands-on lab experience, working closely with labs that match their interests. The course

https://www.multipark.lu.se/article/advanced-neuroscience-course-future-neuroscientists - 2025-10-19

A study at Lund University reveals that traumatic brain injury alters the small vessels in the brain, resulting in an accumulation of amyloid beta — a hallmark of Alzheimer’s disease. The findings suggest that vascular dysfunction could be an early driver in neurodegenerative disorders rather than being caused by neuronal damage. The study is published in Acta Neuropathologica. An increased risk o

https://www.multipark.lu.se/article/cracking-alzheimers-code-how-brain-trauma-triggers-disease - 2025-10-19

This year, MultiPark has the pleasure of welcoming two new research groups. The Mackenzie Lab aims to decode the neurobiological underpinnings of emotion through experimental studies in animal models. Jacob Vogel’s team uses AI to analyze clinical data for improved understanding as well as patient-tailored diagnosis and care of neurodegenerative disease patients. Say hello to Åsa Mackenzie and Jac

https://www.multipark.lu.se/article/multipark-grows-new-research-groups - 2025-10-19

What role does an inflammatory protein have in disease development? Which neuronal circuits cause different symptoms? How may diabetes affect Parkinson’s disease? Can motor signs be identifies early in individuals at risk for the disease? And how should patients in very advanced disease stages be treated to maintain their quality of life? These questions may soon have answers thanks to several ong

https://www.multipark.lu.se/article/molecule-patient-six-promising-projects-advance-parkinsons-research - 2025-10-19

Researchers at Lund University and Washington University have identified a blood marker that reflects the amount of Alzheimer’s pathology in the brain. This discovery may play a key role in determining who is most likely to benefit from the new Alzheimer’s drugs. In brief:A newly discovered blood marker, MTBR-tau243, can reveal how much Alzheimer’s disease pathology is present in the brain. The hi

https://www.multipark.lu.se/article/new-reliable-blood-marker-reveals-extent-alzheimers-pathology-brain - 2025-10-19

A simpler method of analysing blood samples for Alzheimer’s disease has been tested in a large multicentre study, led by Lund University in Sweden. “This is a major step in bringing simple blood tests for Alzheimer’s disease into the healthcare system globally,” say the researchers behind the study. In brief:The blood-based marker (P-tau217) may start to change several years before the onset of Al

https://www.multipark.lu.se/article/more-opportunities-test-alzheimers-using-new-analytical-method - 2025-10-19

Meet our scientist Gesine Paul-Visse to learn what happens at the interface where the brain and the body meet: the blood-brain barrier. Here, a very specialized cell, the pericyte, protects the brain and responds strongly to disease. Gesine Paul-Visse leads Translational Neurology, one of MultiPark’s research groups. As both a neurologist and a researcher, she has focused on neurodegeneration for

https://www.multipark.lu.se/article/meet-our-scientists-podcast-gesine-paul-visse-about-brains-frontline - 2025-10-19

Researchers at MultiPark have uncovered in mice how the protein TDP-43, known for its role in several neurodegenerative diseases, disrupts the hypothalamus, the brain’s key center for metabolic control. Their study sheds new light on the role of TDP-43 in metabolic and psychiatric symptoms shared across frontotemporal dementia, Huntington’s disease, and ALS – findings that could support the develo

https://www.multipark.lu.se/article/protein-mismanagement-brains-control-center-fuels-early-symptoms-neurodegenerative-diseases - 2025-10-19

An experimental study from Lund University reveals for the first time that different Parkinson’s medications affect brain activity in distinct ways. This could explain why some patients develop impulsive and compulsive behaviors as a result of their treatment. The findings have been published in NPJ Parkinson’s Disease. Upon receiving treatment for their motor symptoms, many patients with Parkinso

https://www.multipark.lu.se/article/brain-activation-pattern-behind-impulsivity-parkinsons-treatment-discovered - 2025-10-19

Meet our scientist, Dr. Niklas Mattsson-Carlgren! He explains why studying biomarkers is essential to advancing Alzheimer’s research. Niklas Mattsson-Carlgren is part of the Clinical Memory Research group, a leading centre in the development and evaluation of novel biomarkers for Alzheimer’s disease. In this podcast episode, he discusses why biomarker research is key not only to detecting but also

https://www.multipark.lu.se/article/meet-our-scientists-podcast-niklas-mattsson-carlgren-about-biomarkers-and-future-alzheimers - 2025-10-19

With over 15 research groups dedicated to Alzheimer’s disease research, MultiPark’s goal is to understand the origins of the disease, develop early diagnostics, and improve treatments. The multidisciplinary approach sheds light on the disease from several angles, bridging basic research with clinical investigations. Here are five projects. September is World Alzheimer’s Month. Globally, around 40

https://www.multipark.lu.se/article/alzheimers-awareness-five-research-projects-shaping-future-understanding-diagnosis-and-care - 2025-10-19

For decades, large stretches of human DNA were dismissed as ‘junk’ and considered to serve no real purpose. In a new study in Cell Genomics, researchers at Lund University in Sweden show that the repetitive part of the human genome plays an active role during early brain development and may also be relevant for understanding brain diseases. DNA carries the complete set of instructions an organism

https://www.multipark.lu.se/article/why-repetitive-dna-matters-human-brain-evolution-and-disease - 2025-10-19

Enormous amounts of data about Alzheimer’s Disease have been generated from clinical studies so far. Still, the molecular drivers of Alzheimer’s Disease are largely unknown. With the TAU-TIME project, Jacob Vogel aims to advance knowledge by developing an AI tool that brings together known biological mechanisms with data from patients with the disease. Recent funding from the European Research Cou

https://www.multipark.lu.se/article/time-unite-lab-and-clinic-15-million-eu-build-ai-model-alzheimers-disease - 2025-10-19